Form 4 for GH Guardant Health, Inc.
Accepted 2022-08-19 00:00:00 ET · period of report 2022-08-17 · accession 0001576280-22-000071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-19 | 2022-08-17 | GH | Kalia Kumud | CIO | S - Sale | $51.39 | -2,000 | 18.5K | -10% | -$102.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2022-08-17 | S | D | 2,000 | $51.39 | 18,530 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $51.3812 to $51.395, inclusive. The Reporting Persons undertake to provide to theIssuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above |